67 related articles for article (PubMed ID: 25367940)
1. RBM4-regulated alternative splicing suppresses tumorigenesis.
Cancer Discov; 2014 Nov; 4(11):1253. PubMed ID: 25367940
[TBL] [Abstract][Full Text] [Related]
2. The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression.
Wang Y; Chen D; Qian H; Tsai YS; Shao S; Liu Q; Dominguez D; Wang Z
Cancer Cell; 2014 Sep; 26(3):374-389. PubMed ID: 25203323
[TBL] [Abstract][Full Text] [Related]
3. SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1α in lung cancer cells through alternative splicing mechanism.
Chang HL; Lin JC
Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118550. PubMed ID: 31491447
[TBL] [Abstract][Full Text] [Related]
4. The impact of RNA binding motif protein 4-regulated splicing cascade on the progression and metabolism of colorectal cancer cells.
Liang YC; Lin WC; Lin YJ; Lin JC
Oncotarget; 2015 Nov; 6(35):38046-60. PubMed ID: 26506517
[TBL] [Abstract][Full Text] [Related]
5. RBM4 modulates the proliferation and expression of inflammatory factors via the alternative splicing of regulatory factors in HeLa cells.
Wang WY; Quan W; Yang F; Wei YX; Chen JJ; Yu H; Xie J; Zhang Y; Li ZF
Mol Genet Genomics; 2020 Jan; 295(1):95-106. PubMed ID: 31489484
[TBL] [Abstract][Full Text] [Related]
6. SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer.
Lv Y; Zhang W; Zhao J; Sun B; Qi Y; Ji H; Chen C; Zhang J; Sheng J; Wang T; Dominguez D; Liu H; Liu Q; Meng S; Li X; Wang Y
Signal Transduct Target Ther; 2021 Mar; 6(1):108. PubMed ID: 33664238
[TBL] [Abstract][Full Text] [Related]
7. Functional pre- mRNA trans-splicing of coactivator CoAA and corepressor RBM4 during stem/progenitor cell differentiation.
Brooks YS; Wang G; Yang Z; Smith KK; Bieberich E; Ko L
J Biol Chem; 2009 Jul; 284(27):18033-46. PubMed ID: 19416963
[TBL] [Abstract][Full Text] [Related]
8. A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer.
de Miguel FJ; Pajares MJ; Martínez-Terroba E; Ajona D; Morales X; Sharma RD; Pardo FJ; Rouzaut A; Rubio A; Montuenga LM; Pio R
Mol Oncol; 2016 Nov; 10(9):1437-1449. PubMed ID: 27555542
[TBL] [Abstract][Full Text] [Related]
9. Selective regression of cancer cells expressing a splicing variant of AIMP2 through targeted RNA replacement by trans-splicing ribozyme.
Won YS; Lee SW
J Biotechnol; 2012 Mar; 158(1-2):44-9. PubMed ID: 22285955
[TBL] [Abstract][Full Text] [Related]
10. WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivo.
Markus MA; Heinrich B; Raitskin O; Adams DJ; Mangs H; Goy C; Ladomery M; Sperling R; Stamm S; Morris BJ
Exp Cell Res; 2006 Oct; 312(17):3379-88. PubMed ID: 16934801
[TBL] [Abstract][Full Text] [Related]
11. The RNA-binding protein QKI suppresses cancer-associated aberrant splicing.
Zong FY; Fu X; Wei WJ; Luo YG; Heiner M; Cao LJ; Fang Z; Fang R; Lu D; Ji H; Hui J
PLoS Genet; 2014 Apr; 10(4):e1004289. PubMed ID: 24722255
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
Dammann R; Li C; Yoon JH; Chin PL; Bates S; Pfeifer GP
Nat Genet; 2000 Jul; 25(3):315-9. PubMed ID: 10888881
[TBL] [Abstract][Full Text] [Related]
13. RNA-binding protein CELF6 modulates transcription and splicing levels of genes associated with tumorigenesis in lung cancer A549 cells.
Ma H; Liu G; Yu B; Wang J; Qi Y; Kou Y; Hu Y; Wang S; Wang F; Chen D
PeerJ; 2022; 10():e13800. PubMed ID: 35910766
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of SAMD9 suppresses tumorigenesis and progression during non small cell lung cancer.
Ma Q; Yu T; Ren YY; Gong T; Zhong DS
Biochem Biophys Res Commun; 2014 Nov; 454(1):157-61. PubMed ID: 25450373
[TBL] [Abstract][Full Text] [Related]
15. Splicing factor poly(rC)-binding protein 1 is a novel and distinctive tumor suppressor.
Guo J; Jia R
J Cell Physiol; 2018 Jan; 234(1):33-41. PubMed ID: 30132844
[TBL] [Abstract][Full Text] [Related]
16. Nuclear Aurora kinase A switches m
Li S; Qi Y; Yu J; Hao Y; He B; Zhang M; Dai Z; Jiang T; Li S; Huang F; Chen N; Wang J; Yang M; Liang D; An F; Zhao J; Fan W; Pan Y; Deng Z; Luo Y; Guo T; Peng F; Hou Z; Wang C; Zheng F; Xu L; Xu J; Wen Q; Jin B; Wang Y; Liu Q
Signal Transduct Target Ther; 2022 Apr; 7(1):97. PubMed ID: 35361747
[TBL] [Abstract][Full Text] [Related]
17. RBM4 regulates cellular senescence via miR1244/SERPINE1 axis.
Wang L; Zhang X; Sheng J; Chen L; Zhi L; Zheng Q; Qi Y; Wang L; Zhang J; Zhao J; Wang Y; Liu SX; Sun MZ; Zhang W
Cell Death Dis; 2023 Jan; 14(1):27. PubMed ID: 36639375
[TBL] [Abstract][Full Text] [Related]
18. The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression.
Ezponda T; Pajares MJ; Agorreta J; Echeveste JI; López-Picazo JM; Torre W; Pio R; Montuenga LM
Clin Cancer Res; 2010 Aug; 16(16):4113-25. PubMed ID: 20682707
[TBL] [Abstract][Full Text] [Related]
19. Cell stress modulates the function of splicing regulatory protein RBM4 in translation control.
Lin JC; Hsu M; Tarn WY
Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2235-40. PubMed ID: 17284590
[TBL] [Abstract][Full Text] [Related]
20. Alpha CP-4, encoded by a putative tumor suppressor gene at 3p21, but not its alternative splice variant alpha CP-4a, is underexpressed in lung cancer.
Pio R; Zudaire I; Pino I; Castaño Z; Zabalegui N; Vicent S; Garcia-Amigot F; Odero MD; Lozano MD; Garcia-Foncillas J; Calasanz MJ; Montuenga LM
Cancer Res; 2004 Jun; 64(12):4171-9. PubMed ID: 15205328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
